# LNTH PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/LNTH
Company: Lantheus Holdings

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with LNTH.

## LNTH PDUFA Milestones

- 2026-06-29 — PDUFA — LNTH-2501 (Ga 68 edotreotide) treating Neuroendocrine tumors (NETs)
  Company: Lantheus Holdings
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/LNTH
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the LNTH PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with LNTH, including decision dates, application stage, and summary details when available.
### Where can I find more context for LNTH?

Use the BioPharmSignal company page for LNTH to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.